SHC NASDAQ
Credit Risk of going bust: lower than 70% of companies Debt: 30.2% of company value Bonds: $49.6M held by 110 funds, 205 bp over Treasuries → details ▾
If the stock fell to about $0.44 (down 98%), Sotera Health Company would be worth roughly what it owes.
Total debt $2.27B against a stock market value of $5.24B.
Distance to default 7.48 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.09B (short-term plus half of long-term), stock volatility 28.4%; Altman Z'' 1.47. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Broadview Heights, OH 44147
US
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Petras Michael B. Jr | S-Sale | 294,515 | $18.50 | 2026-08-17 |
| Petras Michael B. Jr | S-Sale | 850,000 | $18.50 | 2026-08-17 |
| Rutz Michael P | S-Sale | 150,000 | $18.84 | 2026-08-07 |
| Lyons Jonathan M. | F-InKind | 11,316 | $17.98 | 2026-08-05 |
| SHADER ALTON | A-Award | 375,939 | — | 2026-05-26 |